Natera (NTRA) Reports Q4 Earnings: What Key Metrics Have to Say

Zacks
03-07

For the quarter ended December 2024, Natera (NTRA) reported revenue of $476.06 million, up 53% over the same period last year. EPS came in at -$0.41, compared to -$0.64 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $471.92 million, representing a surprise of +0.88%. The company delivered an EPS surprise of +2.38%, with the consensus EPS estimate being -$0.42.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Natera performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Tests Processed Volume: 792,800 compared to the 771,561 average estimate based on three analysts.
  • Revenues- Licensing and other: $3.15 million versus the four-analyst average estimate of $3.48 million. The reported number represents a year-over-year change of -18.3%.
  • Revenues- Product: $472.90 million compared to the $406.47 million average estimate based on four analysts. The reported number represents a change of +53.9% year over year.
View all Key Company Metrics for Natera here>>>

Shares of Natera have returned -19.2% over the past month versus the Zacks S&P 500 composite's -5.6% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Natera, Inc. (NTRA) : Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10